Welcome to RiskMastery's Breakout Stocks - Stocks with breakout potential. In this edition, we'll be looking at NASDAQ:CLPT ... I believe this code is at a point of potential volatility. If price can hold above $7.15 ... Bullish potential may be unlocked. My key upside targets include: - $7.92 (Conservative) - $9.24 (Medium) - $10.55 (Aggressive) ...
Bullish Fundamental - High inflationary Macro environment / no fear sentiment - Funds Accumulation/Distribution - PE - PEG - P/FCF - Top Sector / Industry / Leader - Long term uptrend still intact Technical - Momentum Theory Indicator - bottomed broke out - Price action formation ( falling wedge ) - Broke Trend line - Above 200MA - POC - ST ok - Bullish...
Descending triangle with suggested Targets and stop . Play it with small size if you are new to trading and descending triangle pattern.
$CLPT looks to be breaking out pre-market on news that it's medical delivery system is being used in a new clinical trial. News here: t.co I do not yet have a position, I will be watching after the open today to see the reaction. Warning, this is a bio-tech stock and can be very volatile. Just thought I'd bring it to your attention. ClearPoint Neuro, Inc....
Long CLPT, great fundamentals. Stop at 21.4 (on a close only)
I'll start by saying that $CLPT has a lot of tailwinds that can push this to $50 a lot sooner. With that being said I'm a rookie to the art of TA, still learning. I will say that looking at the fundamentals of this stock is alarming. I'm late to this party but I'm here with a 6-pack of shares! Will $CLPT reach $50, YES! of course, the market may also bring this...
Contextual immersion trading strategy idea. ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $8,00; stop-loss — $7,31. Information about...
Clearpoint Neuro, functional neurosurgery platform with rapid growth within the biologics & gen therapy segment. Breakout out of a multi-year trend with re-test of previous resistance level on low volume. Expecting this to pop over the the next few months with the continued net growth and EPS.
Clearpoint Neuro, Inc. engages in the development and commercialization of innovative platforms for performing minimally invasive surgical procedures in the brain and heart. It conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform is comprises of ClearPoint system and ClearTrace system. The company was...